Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-18

Clinical Trial Update: Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of imipramine for esophageal hypersensitivity and functional heartburn in patients with gastroesophageal reflux disease ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine (imipramine)

Snippet

Sponsor: Mahidol University | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED